Drug Type Chemical drugs |
Synonyms sazetidine |
Target |
Mechanism α4β2 receptor agonists(α4β2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyskinesia, Drug-Induced | Preclinical | US | 01 Aug 2013 | |
Dyskinesia, Drug-Induced | Preclinical | US | 01 Aug 2013 | |
Memory Disorders | Preclinical | US | 20 Jul 2006 | |
Neuralgia | Preclinical | US | 20 Jul 2006 | |
Parkinson Disease | Preclinical | US | 20 Jul 2006 |